News

Abbott's Volt™ PFA System, the latest generation of cardiac ablation technology, is designed for people battling heart rhythm disorders such as atrial fibrillation (AFib)

Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, making SANSA the first home sleep apnea test...

Bristol Myers Squibb Press Release PRINCETON, N.J. -- Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis® (apixaban), an oral anticoagulant relied upon by...

Pulse Biosciences Press Release HAYWARD, Calif. -- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today...

MIT-alumni-founded Thermedical advances novel deep-tissue ablation technology to address critical unmet needs in severe ventricular tachycardia

Milestone Pharmaceuticals Press Release MONTREAL and CHARLOTTE, N.C., Dec. 12, 2025 -- Milestone® Pharmaceuticals Inc.  (Nasdaq: MIST) today announced that the U.S. Food and Drug Administration (FDA) approved its first...

Atrial fibrillation is rising at an alarming pace, and its clinical impact continues to deepen. Atrial fibrillation continues to expand in scale and complexity, with the Centers for Disease Control and Prevention estimating that 12.1...